Extending analyses to other non-sirtuin deacetylases, we found that DVL-1 co-precipitates with HDAC1, a class I histone lysine deacetylase (HDAC), which is over-expressed in breast cancer cells (Fig. 3A). Here, HDAC9 is linked to breast carcinoma.